159 related articles for article (PubMed ID: 37953186)
1. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S
Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186
[TBL] [Abstract][Full Text] [Related]
2. Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder.
Klose C; Gordon O; Sparks A; Whalen M
Clin Genitourin Cancer; 2023 Dec; 21(6):703-709. PubMed ID: 37336704
[TBL] [Abstract][Full Text] [Related]
3. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
4. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
5. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
Tarin TV; Power NE; Ehdaie B; Sfakianos JP; Silberstein JL; Savage CJ; Sjoberg D; Dalbagni G; Bochner BH
Eur Urol; 2012 May; 61(5):1025-30. PubMed ID: 22342773
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L
BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729
[TBL] [Abstract][Full Text] [Related]
8. Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database.
Monaghan TF; Flores VX; Suss NR; Robins DJ; Smith MT; McNeil BK; Hyacinthe LM; Weiss JP; Winer AG
Int Urol Nephrol; 2021 Feb; 53(2):235-239. PubMed ID: 32865771
[TBL] [Abstract][Full Text] [Related]
9. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
[TBL] [Abstract][Full Text] [Related]
10. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
11. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
Rink M; Shariat SF; Xylinas E; Fitzgerald JP; Hansen J; Green DA; Kamat AM; Novara G; Daneshmand S; Fradet Y; Tagawa ST; Bastian PJ; Kassouf W; Trinh QD; Karakiewicz PI; Fritsche HM; Tilki D; Chun FK; Volkmer BG; Babjuk M; Merseburger AS; Scherr DS; Lotan Y; Svatek RS
World J Urol; 2012 Dec; 30(6):807-14. PubMed ID: 22832587
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
13. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer.
Perera M; McGrath S; Sengupta S; Crozier J; Bolton D; Lawrentschuk N
Nat Rev Urol; 2018 Nov; 15(11):686-692. PubMed ID: 30104615
[TBL] [Abstract][Full Text] [Related]
14. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
[TBL] [Abstract][Full Text] [Related]
15. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
16. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
Lenis AT; Lec PM; Michel J; Brisbane W; Golla V; Sharma V; Gollapudi K; Blumberg J; Chamie K
Urol Oncol; 2020 Oct; 38(10):796.e7-796.e14. PubMed ID: 32446641
[TBL] [Abstract][Full Text] [Related]
17. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
Morton E; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2023 May; 41(5):255.e7-255.e14. PubMed ID: 36470805
[TBL] [Abstract][Full Text] [Related]
18. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
Bochner BH; Cho D; Herr HW; Donat M; Kattan MW; Dalbagni G
J Urol; 2004 Oct; 172(4 Pt 1):1286-90. PubMed ID: 15371825
[TBL] [Abstract][Full Text] [Related]
19. Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.
Cha EK; Sfakianos JP; Sukhu R; Yee AM; Sjoberg DD; Bochner BH
BJU Int; 2018 Oct; 122(4):627-632. PubMed ID: 29633530
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
Moschini M; Afferi L; Gandaglia G; D'Andrea D; Zamboni S; Di Bona C; Mordasini L; Mattei A; Baumeister P; Martini A; Burgio G; Shariat SF; Sanchez-Salas R; Cathelineau X; Stabile A; Zaffuto E; Salonia A; Colombo R; Necchi A; Montorsi F; Briganti A; Gallina A
Eur Urol Focus; 2021 Sep; 7(5):1067-1074. PubMed ID: 33020030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
